1[1]Lane DP.Cancer.A death in the life of p53.Nature,1993,362(6423):786-787
2[2]Chan AT,Teo PM,Leung TW,et al.The role of chemotherapy in the management of nasopharyngeal carcinoma.Cancer,1998,82(6):1003-1012
3[3]Kerr JFR.Shrinkage necrosis:a distinct mode of cellular death.J Pathol,1971,105(1):13-20
4[4]Kerr JFR,Searle J.A suggested explanation for the paradoxically slow growth rate of basal-cell carcinomas that contain numerous mitotic figures,1972,107(1):41-44
5[5]Hamada S,Fujita S.DAPI staining improved for quantitative cytofluorometry.Histochemistry,1983,79(2):219-226
6[6]Gavrieli Y,Sherman Y,Ben-Sasson SA.Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation.J cell Biol,1992,119(3):493-501
7[7]Carbonari M,Cibati M,Fiorilli M,et al.Measurement of apoptotic cells in peripheral blood.Cytometry,1995,22(3):161-167
8[8]Strater J,Gunther AR,Bruderlein S,et al.Microwave irradiation of paraffin-embedded tissue sensitizes the TUNEL method for in situ detection of apoptotic cells.Histochemistry,1995,103(2):157-160
9[9]Eastman A.Activation of programmed cell death by anticancer agents:cisplatin as a model system.Cancer Cells,1990,2(8-9):275-280
10[10]Lowe SW.Cancer therapy and p53.Curr Opin Oncol,1995,7(6):547-553
